Market dynamics are ripe for M&A activity. But before being enticed by a mirage, leaders must revisit old lessons.

Principal, Health and Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman

Health plans must maintain a competitive portfolio and double-down on their offerings.

Partner, Health & Life Sciences, Oliver Wyman
Principal, Health & Life Sciences, Oliver Wyman
Senior Consultant, Oliver Wyman
Principal, FSA, MAAA, Oliver Wyman

Cost Transformation Amidst Uncertainty

Establish and aim towards a North Star to ensure your organization heads in the direction you want it to.

Partner, Health & Life Sciences, Oliver Wyman
Principal, Health & Life Sciences, Oliver Wyman
Senior Consultant, Oliver Wyman

A Guide to Economic Recovery for Health System CFOs

How prioritizing long-term organizational changes immediately will ensure stability post-crisis.

Partner, Health & Life Sciences, Oliver Wyman
Partner and Chief Medical Officer, Health and Life Sciences, Oliver Wyman
Principal, Health & Life Sciences, Oliver Wyman
Global Head, Provider, Health and Life Sciences, Oliver Wyman

The coronavirus is transforming the status quo of cost, sustainability, and affordability.

Partner, Health and Life Sciences, Oliver Wyman
Global Head, Provider, Health and Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman

Insights in your inbox

Subscribe

Part 3: One Size Does Not Fit All

A closer look at unemployment, member migration, and financial impact amidst an ever-changing pandemic.

Partner, Health & Life Sciences, Oliver Wyman
Principal, Health & Life Sciences, Oliver Wyman
Senior Consultant, Oliver Wyman

Mindful actions from the top down will help organizations turn anxiety into productivity.

Partner, Organizational Effectiveness, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman

Considerations for the pricing of health insurance products amidst a global crisis.

Partner, Health & Life Sciences, Oliver Wyman
Senior Advisor, Health & Life Sciences, Oliver Wyman

Part 2: Healthcare’s ‘Corona Effect’

Ten expectations regarding voluntary offerings, telemedicine, direct contracting, and more as COVID-19 unfolds.

Partner, Health & Life Sciences, Oliver Wyman
Principal, Health & Life Sciences, Oliver Wyman

A closer look at how new healthcare reform is helping providers navigate COVID-19's uncertainty.

Partner, Nixon Peabody
Partner, Health & Life Sciences, Oliver Wyman
Partner and Chief Medical Officer, Health and Life Sciences, Oliver Wyman
Global Head, Provider, Health and Life Sciences, Oliver Wyman

Insights in your inbox

Subscribe
Load More